Spots Global Cancer Trial Database for Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery
Official Title: Study of GSK2302032A Antigen-Specific Cancer Immunotherapeutic in Patients With Resectable Non-Small Cell Lung Cancer
Study ID: NCT01159964
Conditions
Study Description
Brief Summary: The purpose of this clinical study is to assess the safety and immunogenicity of the immunotherapeutic product GSK 2302032A when given to Non-Small Cell Lung Cancer (NSCLC) patients, after tumor removal by surgery.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Newark, Delaware, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Rochester, Minnesota, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, Philadelphia, Pennsylvania, United States
GSK Investigational Site, Everett, Washington, United States
GSK Investigational Site, Seattle, Washington, United States
GSK Investigational Site, Montpellier, , France
GSK Investigational Site, Nice, , France
GSK Investigational Site, Paris Cedex 12, , France
GSK Investigational Site, Toulouse, , France
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Regensburg, Bayern, Germany
GSK Investigational Site, Regensburg, Bayern, Germany
GSK Investigational Site, Immenhausen, Hessen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Moers, Nordrhein-Westfalen, Germany
GSK Investigational Site, Velbert, Nordrhein-Westfalen, Germany
GSK Investigational Site, Leipzig, Sachsen, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Meldola (FC), Emilia-Romagna, Italy
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Pisa, Toscana, Italy
GSK Investigational Site, Perugia, Umbria, Italy
GSK Investigational Site, Checiny, , Poland
GSK Investigational Site, Lublin, , Poland
GSK Investigational Site, Szczecin, , Poland
GSK Investigational Site, Warszawa, , Poland
GSK Investigational Site, Zakopane, , Poland
GSK Investigational Site, Chelyabinsk, , Russian Federation
GSK Investigational Site, Kazan, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
